Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3
Shiro Kamakura1, Tohru Ohe, Kiyoshi Nakazawa
1Division of Cardiology, National Cardiovascular Center, Suita, Osaka 565-8565, Japan. kamakura@hsp.ncvc.go.jp
Insights
Patients with Brugada syndrome and non-type 1 ECG have a similar prognosis to those with type 1 ECG. Family history of sudden cardiac death and early repolarization predict poor outcomes in Brugada syndrome patients.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Brugada syndrome is a rare genetic disorder that affects the heart's electrical system.
- ST-elevation patterns on an electrocardiogram (ECG) are used to diagnose Brugada syndrome.
- The prognostic significance of non-type 1 (saddleback) ST-elevation in Brugada syndrome remains unclear.
Purpose of the Study:
- To determine the long-term prognosis of patients with Brugada syndrome presenting with non-type 1 ECG.
- To compare the prognosis of patients with non-type 1 ECG to those with the more common type 1 (coved) Brugada-pattern ECG.
Main Methods:
- A prospective study followed 330 probands with Brugada-pattern ECG (type 1 or non-type 1).
- ECG patterns were confirmed using drug provocation tests and multiple recordings.
- Patients were followed for an average of 48.7 months to assess arrhythmic events and syncope.
Main Results:
- The long-term prognosis for patients with non-type 1 ECG was similar to that of patients with type 1 ECG.
- The annual arrhythmic event rate for ventricular fibrillation was 10.2% for type 1 and 10.6% for non-type 1.
- Family history of sudden cardiac death before age 45 and inferolateral early repolarization were independent predictors of fatal arrhythmic events.
Conclusions:
- The type of ST-elevation pattern (type 1 vs. non-type 1) does not significantly alter the long-term prognosis in Brugada syndrome.
- Family history of sudden cardiac death and early repolarization are critical indicators of poor prognosis in Brugada syndrome.
- Spontaneous type 1 ECG and inducibility of ventricular fibrillation during electrophysiological studies were not reliable prognostic markers.
Background:
The prognosis of patients with saddleback or noncoved type (non-type 1) ST-elevation in Brugada syndrome is unknown. The purpose of this study was to clarify the long-term prognosis of probands with non-type 1 ECG and those with coved (type 1) Brugada-pattern ECG.
Methods And Results:
A total of 330 (123 symptomatic, 207 asymptomatic) probands with a coved or saddleback ST-elevation > or = 1 mm in leads V(1)-V(3) were divided into 2 ECG groups-type 1 (245 probands) and non-type 1 (85 probands)-and were prospectively followed for 48.7+/-15.0 months. The absence of type 1 ECG was confirmed by drug provocation test and multiple recordings. The ratio of individuals with a family history of sudden cardiac death (14%) was lower than previous studies. Clinical profiles and outcomes were not notably different between the 2 groups (annual arrhythmic event rate of probands with ventricular fibrillation; type 1: 10.2%, non-type 1: 10.6%, probands with syncope; type 1: 0.6%, non-type 1: 1.2%, and asymptomatic probands; type 1: 0.5%, non-type 1: 0%). Family history of sudden cardiac death at age <45 years and coexistence of inferolateral early repolarization with Brugada-pattern ECG were independent predictors of fatal arrhythmic events (hazard ratio, 3.28; 95% confidence interval, 1.42 to 7.60; P=0.005; hazard ratio, 2.66; 95% confidence interval, 1.06 to 6.71; P=0.03, respectively, by multivariate analysis), although spontaneous type 1 ECG and ventricular fibrillation inducibility by electrophysiological study were not reliable parameters.
Conclusions:
The long-term prognosis of probands in non-type 1 group was similar to that of type 1 group. Family history of sudden cardiac death and the presence of early repolarization were predictors of poor outcome in this study, which included only probands with Brugada-pattern ST-elevation.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy

